RYAN SAVITZ plan to sell securities of Dianthus Therapeutics, Inc. under Form 144

RYAN SAVITZ filed Form 144 to notify SEC of plan to sell 114367 units of Dianthus Therapeutics, Inc. securities around 2026-03-31, with aggregate market value of $9,086,458.15. The total outstanding units is 44471094.0. The amount planned to be sold represents 0.26% of total outstanding units;